Percutaneous local therapies for hepatocellular carcinoma impair gastric function

Percutaneous local therapies, such as percutaneous ethanol injection （PEI）, microwave coagulation and radiofrequency ablation （RFA）, are frequently used worldwide for the treatment of hepatocellular carcinoma （HCC） because of their high effectiveness. Although these treatment modalities can induce e...

Full description

Saved in:
Bibliographic Details
Published in:World journal of gastroenterology : WJG 2006-01, Vol.12 (1), p.157-158
Main Authors: Kinekawa, Fumihiko, Matsuda, Kazuya, Masaki, Tsutomu, Kurokohchi, Kazutaka, Yoneyama, Hirohito, Inoue, Hideyuki, Kurata, Hirohide, Uchida, Yoshihito, Watanabe, Seishiro, Kuriyama, Shigeki
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Carcinoma, Hepatocellular - physiopathology
Carcinoma, Hepatocellular - therapy
Catheter Ablation
Ethanol - administration & dosage
Female
Humans
Injections, Intralesional
Letters To The Editor
Liver Neoplasms - physiopathology
Liver Neoplasms - therapy
Male
Stomach - physiopathology
经皮治疗
肝细胞癌
胃功能
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Percutaneous local therapies, such as percutaneous ethanol injection （PEI）, microwave coagulation and radiofrequency ablation （RFA）, are frequently used worldwide for the treatment of hepatocellular carcinoma （HCC） because of their high effectiveness. Although these treatment modalities can induce effectively coagulated tumor necrosis in the liver, they may cause adverse effects on extrahepatic abdominal organs. There are, however, no published reports on the influence of percutaneous local therapies on the gastric myenteric activity. Therefore, it is unclear whether or not gastric function is affected by percutaneous local therapies. In this study, to make clear the effect of PEI and RFA on the gastric function, we continuously recorded the gastric myoelectric activity by electrogastrography （EGG） and estimated the effect of percutaneous local therapies for HCC on gastric function.
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.v12.i1.157